Borsting Eric J, Rouse Michael W, Mitchell G Lynn, Scheiman Mitchell, Cotter Susan A, Cooper Jeffrey, Kulp Marjean Taylor, London Richard
Southern California College of Optometry, 2575 Yorba Linda Blvd., Fullerton, CA 92831, USA.
Optom Vis Sci. 2003 Dec;80(12):832-8. doi: 10.1097/00006324-200312000-00014.
To assess the validity and reliability of the Convergence Insufficiency Symptom Survey (CISS) in children aged 9 to 18 years. The CISS is the primary outcome measure for a pilot study evaluating two different treatments for convergence insufficiency (CI).
Children with CI were given the CISS twice to assess reliability. CISS scores for the first administration were also compared with scores from children with normal binocular vision to assess the validity of the CISS.
Forty-seven children with CI and 56 children with normal binocular vision participated in the study. Reliability was assessed using intraclass correlation and 95% limits of agreement for the children with CI. For children with CI, the intraclass correlation was 0.77 (95% confidence interval, 0.613 to 0.873), and the 95% limits of agreement were -10.2 to +12.1. The mean (+/-SD) CISS score was 30.8 +/- 8.4 for the children with CI and 8.4 +/- 6.4 for the children with normal binocular vision. These means were significantly different (p < 0.0001). Good discrimination (sensitivity, 96%; specificity, 88%) was obtained using a score of >/=16.
Children with CI showed a significantly higher CISS symptom score than children with normal binocular vision. The results of the study indicate that the CISS is a valid and reliable instrument to use as an outcome measure for children aged 9 to 18 who are enrolled in clinical research concerning CI.
评估9至18岁儿童集合不足症状调查(CISS)的有效性和可靠性。CISS是一项初步研究的主要结局指标,该研究评估了两种不同的集合不足(CI)治疗方法。
患有CI的儿童接受两次CISS测试以评估可靠性。首次测试的CISS分数还与双眼视力正常儿童的分数进行比较,以评估CISS的有效性。
47名患有CI的儿童和56名双眼视力正常的儿童参与了研究。使用组内相关性和CI患儿的95%一致性界限评估可靠性。对于CI患儿,组内相关性为0.77(95%置信区间,0.613至0.873),95%一致性界限为-10.2至+12.1。CI患儿的平均(±标准差)CISS评分为30.8±8.4,双眼视力正常儿童的评分为8.4±6.4。这些平均值有显著差异(p<0.0001)。使用≥16分可获得良好的辨别力(敏感性为96%;特异性为88%)。
CI患儿的CISS症状评分显著高于双眼视力正常的儿童。研究结果表明,CISS是一种有效且可靠的工具,可作为9至18岁参与CI临床研究儿童的结局指标。